Search Results - "Seror, Raphaële"

Refine Results
  1. 1

    Current and future therapies for primary Sjögren syndrome by Seror, Raphaèle, Nocturne, Gaetane, Mariette, Xavier

    Published in Nature reviews. Rheumatology (01-08-2021)
    “…Primary Sjögren syndrome (pSS) is a systemic autoimmune disease that is characterized by a triad of symptoms that affect all patients (dryness, pain and…”
    Get full text
    Journal Article
  2. 2

    18F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice? by Pean De Ponfilly – Sotier, Marie, Seror, Raphaële, Nocturne, Gaetane, Besson, Florent L.

    Published in Frontiers in medicine (30-11-2022)
    “…18 F-Labeled Fluorodeoxyglucose-Positron Emission Tomography ( 18 F-FDG PET) is a molecular imaging tool commonly used in practice for the assessment of many…”
    Get full text
    Journal Article
  3. 3

    Cancer screening in chronic inflammatory rheumatic diseases by Kedra, Joanna, Seror, Raphaèle

    Published in Joint, bone, spine : revue du rhumatisme (01-07-2023)
    “…Cancer is a major public health concern, and screening for cancer is a on-going issue in our practice. The risk of cancer in patients with chronic inflammatory…”
    Get full text
    Journal Article
  4. 4

    2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus by Aringer, Martin, Costenbader, Karen, Daikh, David, Brinks, Ralph, Mosca, Marta, Ramsey-Goldman, Rosalind, Smolen, Josef S, Wofsy, David, Boumpas, Dimitrios T, Kamen, Diane L, Jayne, David, Cervera, Ricard, Costedoat-Chalumeau, Nathalie, Diamond, Betty, Gladman, Dafna D, Hahn, Bevra, Hiepe, Falk, Jacobsen, Søren, Khanna, Dinesh, Lerstrøm, Kirsten, Massarotti, Elena, McCune, Joseph, Ruiz-Irastorza, Guillermo, Sanchez-Guerrero, Jorge, Schneider, Matthias, Urowitz, Murray, Bertsias, George, Hoyer, Bimba F, Leuchten, Nicolai, Tani, Chiara, Tedeschi, Sara K, Touma, Zahi, Schmajuk, Gabriela, Anic, Branimir, Assan, Florence, Chan, Tak Mao, Clarke, Ann Elaine, Crow, Mary K, Czirják, László, Doria, Andrea, Graninger, Winfried, Halda-Kiss, Bernadett, Hasni, Sarfaraz, Izmirly, Peter M, Jung, Michelle, Kumánovics, Gábor, Mariette, Xavier, Padjen, Ivan, Pego-Reigosa, José M, Romero-Diaz, Juanita, Rúa-Figueroa Fernández, Íñigo, Seror, Raphaèle, Stummvoll, Georg H, Tanaka, Yoshiya, Tektonidou, Maria G, Vasconcelos, Carlos, Vital, Edward M, Wallace, Daniel J, Yavuz, Sule, Meroni, Pier Luigi, Fritzler, Marvin J, Naden, Ray, Dörner, Thomas, Johnson, Sindhu R

    Published in Annals of the rheumatic diseases (01-09-2019)
    “…To develop new classification criteria for systemic lupus erythematosus (SLE) jointly supported by the European League Against Rheumatism (EULAR) and the…”
    Get more information
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Epidemiology of Sjögren syndrome by Beydon, Maxime, McCoy, Sara, Nguyen, Yann, Sumida, Takayuki, Mariette, Xavier, Seror, Raphaèle

    Published in Nature reviews. Rheumatology (01-03-2024)
    “…Sjögren syndrome is a phenotypically varied autoimmune disorder that can occur alone in primary Sjögren syndrome or in association with other connective tissue…”
    Get full text
    Journal Article
  9. 9

    Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study by Mariette, Xavier, Seror, Raphaèle, Quartuccio, Luca, Baron, Gabriel, Salvin, Sara, Fabris, Martina, Desmoulins, Frederic, Nocturne, Gaétane, Ravaud, Philippe, De Vita, Salvatore

    Published in Annals of the rheumatic diseases (01-03-2015)
    “…Increased expression of B cell activating factor (BAFF or B lymphocyte stimulator) may explain the B cell activation characteristic of primary Sjögren's…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Malignancy and the Risks of Biologic Therapies: Current Status by Seror, Raphaèle, Mariette, Xavier

    “…Cancer is a common event in patients with rheumatic diseases. In some cases, the disease, its risk factors, or its treatment could play a role in favoring…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Cost-effectiveness of rituximab strategies in rheumatoid arthritis by Seror, Raphaèle, Mariette, Xavier

    Published in The Lancet (British edition) (28-01-2017)
    “…We read with interest the Article by Duncan Porter and colleagues (July 16, p 239), 1 and the accompanying comment by Tom Huizinga and colleagues (July 16, p…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study by De Vita, Salvatore, Quartuccio, Luca, Seror, Raphaèle, Salvin, Sara, Ravaud, Philippe, Fabris, Martina, Nocturne, Gaétane, Gandolfo, Saviana, Isola, Miriam, Mariette, Xavier

    Published in Rheumatology (Oxford, England) (01-12-2015)
    “…To report the efficacy and safety of long-term treatment of SS with belimumab, targeting the B-cell-activating factor. Patients with primary SS were included…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Inflammation-targeted therapies and cancer by Kedra, Joanna, Nocturne, Gaetane, Mariette, Xavier, Seror, Raphaèle

    Published in Joint, bone, spine : revue du rhumatisme (01-07-2021)
    “…•Data are reassuring regarding the overall risk of cancer with TNF inhibitors (TNFi).•The risk of lymphoma does not seem to be increased with TNFi.•There is…”
    Get full text
    Journal Article
  19. 19

    Disease activity and patient reported outcome measures in Sjögren's - what are the best tools to evaluate? by Seror, Raphaèle, Rauz, Saaeha, Gosset, Marjolaine, Bowman, Simon J

    Published in Rheumatology (Oxford, England) (02-08-2021)
    “…In primary SS (pSS), clinical features in SS can be divided into two facets: the patient perceived manifestations such as dryness, pain and fatigue, and the…”
    Get full text
    Journal Article
  20. 20